Kurzfassung

An Open Label Cross-Over, Dose Ranging Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of the Subcutaneous Administration of a Human Plasma-Derived C1-Esterase Inhibitor in Subjects with Hereditary Angioedema